Studies from other CNS disorders suggest that the secretion of LCN2 from reactive astrocytes may contribute to the neuropathology by enhancing neuroinflammation or neurotoxicity (reviewed in Lim et al., 2021). This evidence concerns the gene LCN2 and central nervous system disorder.